EWING, N.J.--(BUSINESS WIRE)--Redpoint Bio Corporation (OTCBB: RPBC), a company developing compounds to improve the taste of pharmaceutical, food and beverage products, today announced the termination of its research & development collaboration and licensing agreement by partner Givaudan, a company based in Vernier, Switzerland. Signed in March of 2007, the collaboration was focused on the discovery of novel taste modulators for use in the food and beverage industry.
